Product Spotlight: Xeomin

Product Spotlight: Xeomin

by Natalie (SU)
In July 2011 the Food & Drug Administration (FDA), approved Xeomin for cosmetic use, similar to Botox and Dysport. Prior to this, Xeomin (incobotulinumtoxinA), manufactured by Merz Pharmaceuticals, was only being used to treat adults with cervical dystonia (abnormal neck pain and movements), blepharospasm (abnormal spasms or involuntary blinking of eyelids), and upper limb spasticity, or stiffness.